SUIC Worldwide Holdings Ltd. 8-K

What Happened
SUIC Worldwide Holdings Ltd. filed an 8-K on July 10, 2026 announcing a share exchange agreement to acquire 51% of Vision Renu Corporation. Under the agreement SUIC will issue 30,000,000 shares of SUIC common stock (the “Exchange Shares”), which the filing says represent approximately 35% of SUIC on a fully‑diluted basis. The filing states the parties intend the transaction to qualify as a tax‑free reorganization under Section 368(a). At the effective time the board was reconstituted: Harriette Lo, Han Wei Wang and Yee Wei Tan resigned from their director/officer roles; Chen King Te was appointed Chairman, director and Chief Executive Officer; Shan Hua Peng was appointed director and Chief Financial Officer.

Key Details

• Transaction date filed: July 10, 2026 (Share Exchange Agreement filed as Exhibit 2.1).
• Consideration: 30,000,000 SUIC common shares issued in exchange for Vision Renu equity.
• Ownership stated: SUIC to acquire 51% of Vision Renu; Exchange Shares described as ~35% of SUIC on a fully diluted basis.
• Business acquired: Vision Renu — Taiwan-based R&D/manufacturer of high‑tech medical devices (notably a scleral micro‑ablation laser for presbyopia and a TMS device for depression). Filing notes FDA work on the laser system, Taiwan approval and hundreds of TMS orders in Asia.
• Financial filings: Audited Vision Renu financial statements for 2024 and 2025 included as Exhibit 99.1; SUIC will file required pro forma and interim reports within 70 days (via 8-K/A).

Why It Matters
This is a material strategic transaction: SUIC is issuing a large block of shares (30 million) and changing management, which can meaningfully affect ownership, control and the company’s business focus. Vision Renu brings medical‑device products and contracts that SUIC now adopts as its business; audited historical results are attached and pro forma financials are forthcoming. Retail investors should note the share issuance (potential dilution), the management turnover (new CEO and CFO), and watch for the upcoming pro forma/interim reports for the combined company’s financial picture.